Skip to content
Open in App
Becton Dickinson logo

Becton Dickinson

web2

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, labo...

Symbol · 1BDX
Company profile

About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Gary Sorsher assumes role as chief quality officer

KEY STEP

BD announced that Gary Sorsher would become executive vice president and chief quality officer effective September 8, 2026, succeeding Jeff Silvestri, who is retiring in October.

Roadmap reference
People

Company team

JW

Jeffrey W. Henderson

Independent Director

Company leadership profile.

BL

Bertram Lee Scott

Independent Director

Company leadership profile.

WM

William M. Brown

Independent Director

Company leadership profile.

GJ

Gregory J. Hayes

Independent Director

Company leadership profile.

TE

Thomas E. Polen

President, CEO & Chairman

Company leadership profile.

CI

Christopher Ian Montague Jones

Independent Director

Company leadership profile.

CM

Catherine M. Burzik

Independent Director

Company leadership profile.

RA

Robert Andrew Eckert

Lead Independent Director

Company leadership profile.

TM

Timothy M. Ring

Independent Director

Company leadership profile.

CL

Carrie L. Byington

Independent Director

Company leadership profile.

JW

Joanne Waldstreicher

Independent Director

Company leadership profile.

RL

Robert Luther Huffines

Independent Director

Company leadership profile.

JM

Jacqueline Marie Wright

Independent Director

Company leadership profile.

Expert coverage

2 experts evaluated Becton Dickinson.

Orbitrum research

Experts evaluating Becton Dickinson

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment